AGP Picks
View all

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

Press releases published on November 17, 2026

Zenas BioPharma Launches The Distance Between Platform to Bring Greater Visibility to the Hidden Burden of IgG4-Related Disease
Nutriband Announces USPTO Notice of Allowance for Commercial Brand Name Trademarks for Its Abuse-Deterrent Fentanyl Transdermal System
SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with…
Noom Launches OpenRx, a New Peptide and Preventive Health Brand
Greenwich LifeSciences Announces Acceptance of Abstracts at SABCS 2026
Hyalex Orthopaedics Announces First Commercial Case with the Slalom MTP Implant for Hallux Rigidus
Cognition Therapeutics Announces CTAD Poster Highlighting Screening Efficiencies with p-Tau217 in the Ongoing Phase 2 START Study
Eikon Therapeutics Announces Clearance to Proceed with First-in-Human Phase 1/2 Study for Novel Androgen Receptor Antagonist EIK1006 in Advanced Metastatic Prostate Cancer 
Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026
Biocomposites welcomes new clinical pathway for local infection management in severe pressure ulcers
CancerVax Successfully Kills Cancer Cells in Landmark Test
Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development
ProMIS Neurosciences Licenses Next-Generation TXP1 Brain-Selective Shuttling Technology from Ossianix to Expand PMN310 Franchise and Pipeline
Commit Biologics announces final close of $60 million seed financing to advance complement-powered immune engagers toward the clinic
Rapid Nutrition Announces SystemLS AI Mobile App to Accelerate International Growth and Create Recurring Subscription Revenue Opportunity
AriBio’s Oral AR1001 Meets Primary Efficacy Objective in Prespecified Monotherapy Population in Phase 3 POLARIS-AD Trial
AGC Biologics Welcomes Multiple Cell Therapy Projects to New Yokohama Site
AGCバイオロジクス、横浜の新施設で複数の細胞治療プロジェクトを受注
AGC 바이오로직스, 신규 요코하마 사업장에서 다수의 세포치료제 개발 프로젝트 수주
AGC Biologics Mengalu-alukan Pelbagai Projek Terapi Sel ke Fasiliti Baharu di Yokohama

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthy Living Washington

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.